Drugs / DNN.65.21.005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07270432 | Jan 2026 → Apr 2027 expected | benign prostatic hyperplasia | Ache Laboratorios Farmaceuticos S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNN.65.21.005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07270432 ↗ |